(Q36643667)

15 August 2017

1 reference

title

Aldosterone inhibition reduces the risk of sudden cardiac death in patients with heart failure (English)

1 reference

15 August 2017

Kishlay Anand

1

1 reference

15 August 2017

Aryan N Mooss

series ordinal

2

1 reference

15 August 2017

Syed M Mohiuddin

series ordinal

3

1 reference

15 August 2017

publication date

1 March 2006

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

15-19

1 reference

Sudden cardiac death in the United States, 1989 to 1998.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Sudden cardiac death: epidemiology, transient risk, and intervention assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Frequency of sudden cardiac death and profiles of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Out-of-hospital cardiac arrest--the relevance of heart failure. The Maastricht Circulatory Arrest Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Aldosterone, a new appreciation of its role in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Neurohumoral Activation and Ventricular Arrhythmias in Patients with Decompensated Congestive Heart Failure:

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Aldosterone regulation of gene transcription leading to control of ion transport

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

The role of tumor necrosis factor in the pathophysiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Basic mechanisms in heart failure: the cytokine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Sudden cardiac death after heart failure; symptomatic versus disease treatment? An editorial comment

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Task Force on Sudden Cardiac Death of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2006.001

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2006.001

1 reference

release_vtvjzfr53vgatk6ey2wsjzubny

15 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vtvjzfr53vgatk6ey2wsjzubny

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference